委员会意见第692号摘要:妊娠期及产后急性发作严重高血压的紧急治疗
妊娠期、产时或产后可发生急性发作的严重收缩期高血压、严重舒张期高血压或两者兼有,需紧急降压治疗。标准化循证指南可减少不良母体结局,首次用药应在确诊严重高血压后30-60分钟内尽快给予以降低母体卒中风险。静脉拉贝洛尔和肼屈嗪长期被视为一线药物,即刻释放口服硝苯地平也可考虑为一线治疗,尤其无静脉通路时。
要点
- 急性发作严重高血压需紧急降压,首次用药应在确诊后30-60分钟内尽快给予。
- 静脉拉贝洛尔和肼屈嗪为一线药物,即刻释放口服硝苯地平也可考虑为一线治疗。
- 一线药物连续适当剂量失败时,推荐紧急会诊麻醉科、母胎医学专科或重症监护专科讨论二线干预。
核心结论
- 急性发作严重高血压的孕妇或产后妇女需要紧急降压治疗,首次用药应在确诊严重高血压后30-60分钟内尽快给予以降低母体卒中风险。
研究设计与样本
- 本文为妇产科委员会意见(Obstet Gynecol),由机构制定,基于证据提出推荐条款。
主要发现
- 引入标准化、循证的子痫前期和子痫患者管理临床指南已被证明可降低不良母体结局的发生率。
关键数值与推荐
- 急性发作严重收缩期高血压、严重舒张期高血压或两者兼有的孕妇或产后妇女需要紧急降压治疗。
- 首次一线药物治疗应迅速,在确诊严重高血压后30-60分钟内尽快给予。
- 静脉拉贝洛尔和肼屈嗪长期被视为妊娠期及产后急性发作严重高血压的一线药物。
- 即刻释放口服硝苯地平也可考虑为一线治疗,尤其无静脉通路时。
- 静脉推注拉贝洛尔、肼屈嗪或即刻释放口服硝苯地平以连续适当剂量给药失败时,推荐紧急会诊麻醉科、母胎医学专科或重症监护专科讨论二线干预。
临床怎么用
- 个体和机构应建立机制,在患者出现高血压急症时立即启动给药。
- 治疗应使用一线药物并迅速给予,在确诊严重高血压后30-60分钟内尽快用药。
- 无静脉通路时可考虑即刻释放口服硝苯地平作为一线治疗。
- 一线药物连续适当剂量失败时,推荐紧急会诊麻醉科、母胎医学专科或重症监护专科讨论二线干预。
局限性
- 目前关于钙通道阻滞剂用于该临床指征的信息相对较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute-onset, severe systolic hypertension; severe diastolic hypertension; or both can occur during the prenatal, intrapartum, or postpartum periods. Pregnant women or women in the postpartum period with acute-onset, severe systolic hypertension; severe diastolic hypertension; or both require urgent antihypertensive therapy. Introducing standardized, evidence-based clinical guidelines for the management of patients with preeclampsia and eclampsia has been demonstrated to reduce the incidence of adverse maternal outcomes. Individuals and institutions should have mechanisms in place to initiate the prompt administration of medication when a patient presents with a hypertensive emergency. Treatment with first-line agents should be expeditious and occur as soon as possible within 30-60 minutes of confirmed severe hypertension to reduce the risk of maternal stroke. Intravenous labetalol and hydralazine have long been considered first-line medications for the management of acute-onset, severe hypertension in pregnant women and women in the postpartum period. Although relatively less information currently exists for the use of calcium channel blockers for this clinical indication, the available evidence suggests that immediate release oral nifedipine also may be considered as a first-line therapy, particularly when intravenous access is not available. In the rare circumstance that intravenous bolus labetalol, hydralazine, or immediate release oral nifedipine fails to relieve acute-onset, severe hypertension and is given in successive appropriate doses, emergent consultation with an anesthesiologist, maternal-fetal medicine subspecialist, or critical care subspecialist to discuss second-line intervention is recommended.
引用
- Committee Opinion No. 692 Summary: Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period. Obstet Gynecol. 2017. PMID: 28333812. doi:10.1097/AOG.0000000000002010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。